Endovascular aneurysm repair is a minimally invasive technique for the treatment of abdominal aortic ...

LeMaitre Vascular (NASDAQ: LMAT) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below summarizes their recent ...

Medtronic announced that the FDA has approved new labeling for the company’s Endurant stent graft system for use in the t ...

The Medtronic Endurant stent graft system got FDA approval to remove a warning against use for ruptured abdominal aortic ...

Medtronic (NYSE: MDT) announced today that it received new labeling approval from the FDA for its Endurant stent graft system.

Company announces positive first-in-human study results, the close of a $6.9 million Series A financing, and FDA approval of ...

Humacyte faces high volatility after Symvess approval positive trauma data but repeated dilutive fundraisings and safety concerns. Find out why HUMA is a Buy.

DURHAM, N.C. - Humacyte, Inc. (NASDAQ:HUMA), a $333.55 million market cap biotechnology company whose stock has surged over 21% in the past week, announced positive long-term results for its Symvess ...

Results published in Oxford Academic’s Military Medicine Journal -- After up to 18 months of follow-up patients were observed to have zero ...